Clinical Trial Update: Clinical Study of HiR+X Therapy for Newly Diagnosed Elderly Patients With DLBCL Intolerant to Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of HiR+X Therapy for newly diagnosed elderly patients with Diffuse Large B-Cell Lymphoma who are intolerant to chemotherapy is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• HiR+X Therapy

Snippet

Sponsor: First Affiliated Hospital of Ningbo University | Conditions: DLBCL, Diffuse Large B-Cell Lymphoma | Phase 2 | Status: RECRUITING